Company News, Financial News

Valeant To Purchase PreCision Dermatology

Deal worth an estimated $500 million

Author Image

By: TOM BRANNA

Editor

More acquisitions are on the way for Valeant Pharmaceuticals International, Inc. The company will acquire PreCision Dermatology, Inc. for $475 million in cash, plus an additional $25 million payable upon the achievement of a sales-based milestone.  PreCision develops and markets high quality dermatology products with leading products such as Locoid, Hylatopic, Clindagel, and BenzEFoam.  PreCision expects to have approximately $130 million in revenue in 2014.  The transaction is expected to close...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters